Events

Upcoming Events

Check back soon for more upcoming events!

 


 

Previously Recorded Events

340B Program Perspectives: Insight on Current Contract Pharmacy Issues

The federal 340B drug discount program provides certain providers with substantial discounts on certain covered outpatient drugs. Last year the 340B program saw growth amidst uncertainty related to the use of contract pharmacies. The health care data and analytics firm, IQVIA, reported that in 2021, 340B program sales reached $93.6 billion and grew 15.9% year-on-year. However, last year more pharmaceutical manufacturers announced or implemented a change to not offer the 340B discount to drugs dispensed under contract pharmacy arrangements. The growth, policy, and legal issues of the 340B program are significant not only to impacted health care providers and pharmaceutical manufacturers, but also to other stakeholders such as health plans, data vendors, and even Congress.

This virtual symposium hosted by the Business Advancement Center for Health (BACH) reviewed the latest legal and policy questions under discussion in the Courts and Congress and explain how impacted stakeholders are responding to the ever-evolving 340B program landscape.

Presenters: Thomas Barker, JD (Foley Hoag, LLP); Sayah Nikpay, PhD (University of Minnesota School of Public Health); Faraz Siddiqui, JD, MPH (Hyman, Phelps & McNamara); moderated by Pinar Karaca-Mandic, PhD (Carlson School of Management).

Thank you to Leavitt Partners for their assistance in planning this event!

watch the recorded presentation          Dr. Nikpay Presentation Slide Deck

 

Convene Conference 

Consumerization of Healthcare & Digital Health

Convene Conference is a thought-leadership conference focused on the intersection of healthcare, technology, and data analytics as major solutions to healthcare issues. 

The 4th annual Convene explored consumerism in healthcare and the evolution of digital health innovations to support personalized care. Leaders from the patient, provider, payer, medical device, and regulatory sectors addressed how their organizations are transforming the medical industry to increase access and improve quality of care.

Visit the Convene Conference website to learn more and to watch the session recordings. (Recorded April 26, 2022)

 

Interdisciplinary Health Data Competition

 

Patient Experience in a Hospital Setting

The University of Minnesota is hosting the 3rd annual Health Data Competition to promote interdisciplinary dialogue on how to use data to address current healthcare challenges. Student teams will complete an exploratory analysis of the Hospital Consumer Assessment of Healthcare Provider & Systems (HCAHPS) survey to assess how patient experience in a hospital setting impacts other aspects of care. The required dataset will be announced at the Competition Kickoff on March 16th. This competition is open to all graduate and professional degree-seeking students across the Twin Cities campus. Visit the competition website for more information.

Visit the Competition website to learn more about this year's winners and watch the finalists' presentations. (Recorded April 5, 2022)

 

Robert Wood Johnson Foundation's Systems for Action Research-in-Progress Webinar

 

Social Bonds as a Pooled Financing Mechanism to Address Social Drivers of Health Equity

The University of Minnesota research team partnered with the Minnesota Hospital Association to introduce their new study "Social Bonds as a Pooled Financing Mechanism to Address Social Drivers of Health Equity." The study's Principal Investigator is BACH Founding Director Prof. Pinar Karaca-Mandic. This project investigates if a novel social bond can pool resources across multiple competing health plans to create stable, long-term financing for interventions address social determinants of health and promote racial justice and health equity.  

watch the recorded presentation

Recorded March 2, 2022

 

The Vision for Medicare in the Post-Pandemic Era

Featuring Dr. Meena Seshamani, Director, Center for Medicare

As the country recovers from the pandemic, industry leaders are reimagining how a post-COVID-19 healthcare ecosystem needs to transform so we are positioned to deliver patient-centered, cost-effective value-based care. How do business models need to evolve? How is payment reform responding to new methods of care delivery? How do we measure quality outcomes and define success?

MILI Academic Director, Prof. Pinar Karaca-Mandic and MILI Executive in Residence, Gopal Khanna, hosted a virtual discussion with Dr. Meena Seshamani, the newly appointed Director for the Center for Medicare, on her vision for the future of Medicare, and the challenges and opportunities the industry faces in the post-pandemic era of health. 

Watch the recorded presentation

Recorded on December 1, 2021

 

The Landscape of Nonprofit Health Plans in Minnesota

 

Featuring Minnesota Council of Health Plans, HealthPartners, and Medica

MILI in collaboration with the Minnesota Council of Health Plans (MCHP) hosted a webinar on the landscape of nonprofit health plans in Minnesota. The audience learned about MCHP, the impact of nonprofit health plans, leading industry trends, and the employment outlook.  MILI Academic Director Prof. Pinar Karaca-Mandic led an engaging discussion with Lucas Nesse, (President & CEO, MCHP), Andrea Walsh (President & CEO, HealthPartners), and John Naylor (President & CEO, Medica).   

The Minnesota Council of Health Plans is an association of nonprofit health insurers whose mission is to get Minnesotans the affordable, equitable and quality-based care they need today and in the future. They have worked for more than 30 years to improve care for everyone.    

Watch the recorded presentation

Recorded on November 10, 2021

 

The Changing Market of Biosimilars

Featuring Prime Therapeutics

Biologics have revolutionized the treatment of care, but often at high prices. The Biologics Price Competition and Innovation Act (BPCIA) of 2010 created a pathway for approval and market launch of “biosimilar” products with the goal of introducing affordable alternatives and enhancing competition. As the biosimilar market evolves with new biosimilars coming to market, it is essential to consider patient, provider, payer, manufacturer, and policy dynamics that influence uptake and affordability. 

This virtual panel discussion, led by MILI and Prime Therapeutics leadership, introduces the biosimilars landscape and discusses coverage and pricing of biosimilars, provider-level factors influencing uptake, legislative challenges, and manufacturer perspectives.

watch the recorded presentation           view the presentation slides

Recorded on October 13, 2021

 

Archived Events

Contact Business Advancement Center for Health